Phosphoric Acid

Phosphoric Acid

SCHEMBL516073

O=P([O-])(O)O.O=P([O-])(O)O.[Fe+2]

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC34A1 Q06495 1/20 0.80
LMNA P02545 2/20 0.43
CA2 P00918 1/20 0.42
KDM4E B2RXH2 2/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41
MMP2 P08253 1/20 0.36
THRB P10828 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
FDPS P14324 1/20 0.36
BLM P54132 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CA1 P00915 2/20 0.32
CA4 P22748 2/20 0.32
CA5A P35218 2/20 0.32
CA5B Q9Y2D0 2/20 0.32
TYMS P04818 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL28228965 0.95 SLC34A1 (0.73) SLC34A1LMNACA2KDM4ECYP2C19
Phosphoric Acid SCHEMBL38650899 0.95 SLC34A1 (0.73) SLC34A1LMNACA2KDM4ECYP2C19
Phosphoric Acid SCHEMBL27856436 0.95 SLC34A1 (0.73) SLC34A1LMNACA2KDM4ECYP2C19
Phosphoric Acid SCHEMBL30904476 0.95 SLC34A1 (0.73) SLC34A1LMNACA2KDM4ECYP2C19
Phosphoric Acid SCHEMBL28267479 0.95 SLC34A1 (0.90) SLC34A1LMNACA2KDM4ECYP2C19
Phosphoric Acid SCHEMBL33722645 0.95 SLC34A1 (0.73) SLC34A1LMNACA2KDM4ECYP2C19
Phosphoric Acid SCHEMBL28612552 0.91 SLC34A1 (0.67) SLC34A1LMNACA2KDM4ECYP2C19
Phosphoric Acid SCHEMBL28979850 0.91 SLC34A1 (0.67) SLC34A1LMNACA2KDM4ECYP2C19
Phosphoric Acid SCHEMBL28728424 0.91 SLC34A1 (0.67) SLC34A1LMNACA2KDM4ECYP2C19
Phosphoric Acid SCHEMBL28946695 0.91 SLC34A1 (0.67) SLC34A1LMNACA2KDM4ECYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116550972-B Phosphating modified zero-valent iron material and preparation method and application thereof 四川大学 2025-05-30 CN claimed
CN-119685850-A Electrode material, preparation method and preparation system thereof 北京众和青源科技有限公司 2025-03-25 CN claimed
CN-119530538-A Method for realizing efficient and stable enrichment of actinides by regulating nucleation and growth in colloid crystallization process 同济大学 2025-02-28 CN claimed
CN-116550972-A Phosphating modified zero-valent iron material and preparation method and application thereof 四川大学 2023-08-08 CN claimed
CN-111276693-B Modification method of lithium manganese iron phosphate, modified lithium manganese iron phosphate and application thereof 上海华谊(集团)公司 2022-09-20 CN claimed
CN-112834540-B Determining PBI/H3PO4Method for measuring content of phosphoric acid in doped film 中国科学院大连化学物理研究所 2022-07-05 CN claimed
CN-111392997-B Recycling process of organophosphorus sludge 杭州秀澈环保科技有限公司 2022-03-01 CN claimed
CN-112981424-A Paint processing technology with high stability 云南万里化工制漆有限责任公司 2021-06-18 CN claimed
CN-112834540-A Determining PBI/H3PO4Method for measuring content of phosphoric acid in doped film 中国科学院大连化学物理研究所 2021-05-25 CN claimed
CN-112811476-A Nickel-doped brownmillerite type oxygen carrier and preparation method and application thereof 华中科技大学 2021-05-18 CN claimed
CN-111681824-A Novel low-smoke halogen-free flame-retardant B1-grade cable 上海飞航电线电缆有限公司 2020-09-18 CN claimed
US-20150349343-A1 Low-Cost Method for Making Lithium Transition Metal Olivines with High Energy Density DOW GLOBAL TECHNOLOGIES LLC 2015-12-03 US claimed
EP-2867161-A2 LOW-COST METHOD FOR MAKING LITHIUM TRANSITION METAL OLIVINES WITH HIGH ENERGY DENSITY Dow Global Technologies LLC (US) 2015-05-06 EP claimed
WO-2014004386-A2 LOW-COST METHOD FOR MAKING LITHIUM TRANSITION METAL OLIVINES WITH HIGH ENERGY DENSITY DOW GLOBAL TECHNOLOGIES LLC (US) 2014-01-03 WO claimed
WO-2012001578-A1 SINGLE-STEP SYNTHESIS OF IRON OXIDE NANOPARTICLES KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2012-01-05 WO claimed
US-4636265-A CORROSION RESISTANCE HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1987-01-13 US claimed
US-12594345-B2 Degradable hyaluronic acid hydrogels ASCENDIS PHARMA A/S (DK) 2026-04-07 US disclosed
EP-3744427-B1 PROCESS AND APPARATUS FOR THE TREATMENT OF GAS STREAMS CONTAINING NITROGEN OXIDES BASF SE (DE) 2026-01-28 EP disclosed
EP-0952193-A1 Agent for treating metallic surface, surface-treated metal material and coated metal material Toyo Boseki Kabushiki Kaisha (JP) 1999-10-27 EP disclosed
CN-1101290-A Freshing agent JIANG JINGJIE (CN) 1995-04-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12594345-B2 Degradable hyaluronic acid hydrogels CD44, H1-0, MMP1 SLC34A1 489/4885LMNA 306/4885CA2 78/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.